相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae
Anais Eskenazi et al.
NATURE COMMUNICATIONS (2022)
Can Bacteriophages Replace Antibiotics?
Mikael Skurnik
ANTIBIOTICS-BASEL (2022)
An Optimized Bacteriophage Cocktail Can Effectively Control Salmonella in vitro and in Galleria mellonella
Janet Y. Nale et al.
FRONTIERS IN MICROBIOLOGY (2021)
Genes Influencing Phage Host Range in Staphylococcus aureus on a Species-Wide Scale
Abraham G. Moller et al.
MSPHERE (2021)
Phage engineering and the evolutionary arms race
Huan Peng et al.
CURRENT OPINION IN BIOTECHNOLOGY (2021)
Bacteriophage endolysins - extending their application to tissues and the bloodstream
Mathias Schmelcher et al.
CURRENT OPINION IN BIOTECHNOLOGY (2021)
Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?
Stephen T. Abedon et al.
PHARMACEUTICALS (2021)
Friends or Foes? Rapid Determination of Dissimilar Colistin and Ciprofloxacin Antagonism of Pseudomonas aeruginosa Phages
Katarzyna M. Danis-Wlodarczyk et al.
PHARMACEUTICALS (2021)
Analysis of Selection Methods to Develop Novel Phage Therapy Cocktails Against Antimicrobial Resistant Clinical Isolates of Bacteria
Melissa E. K. Haines et al.
FRONTIERS IN MICROBIOLOGY (2021)
Improving Phage-Biofilm In Vitro Experimentation
Stephen T. Abedon et al.
VIRUSES-BASEL (2021)
Screening for Lysogen Activity in Therapeutically Relevant Bacteriophages
Fernando L. Gordillo Altamirano et al.
BIO-PROTOCOL (2021)
Creature features: The lively narratives of bacteriophages in Soviet biology and medicine
Dmitriy Myelnikov
NOTES AND RECORDS-THE ROYAL SOCIETY JOURNAL OF THE HISTORY OF SCIENCE (2020)
PhageScore: A simple method for comparative evaluation of bacteriophages lytic activity
Maciej Konopacki et al.
BIOCHEMICAL ENGINEERING JOURNAL (2020)
A New High-Throughput Screening Method for Phages: Enabling Crude Isolation and Fast Identification of Diverse Phages with Therapeutic Potential
Nikoline S. Olsen et al.
PHAGE-THERAPY APPLICATIONS AND RESEARCH (2020)
The Virulence Index: A Metric for Quantitative Analysis of Phage Virulence
Zachary J. Storms et al.
PHAGE-THERAPY APPLICATIONS AND RESEARCH (2020)
Directed in Vitro Evolution of Therapeutic Bacteriophages: The Appelmans Protocol
Ben H. Burrowes et al.
VIRUSES-BASEL (2019)
Molecular and Evolutionary Determinants of Bacteriophage Host Range
Patrick A. de Jonge et al.
TRENDS IN MICROBIOLOGY (2019)
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
Rebekah M. Dedrick et al.
NATURE MEDICINE (2019)
Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth
Paul Hyman
PHARMACEUTICALS (2019)
Effect of bacterial growth rate on bacteriophage population growth rate
Dominik Nabergoj et al.
MICROBIOLOGYOPEN (2018)
Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models
Francesca Forti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Contribution of the Immune Response to Phage Therapy
Oleg Krut et al.
JOURNAL OF IMMUNOLOGY (2018)
Selection of Potential Therapeutic Bacteriophages that Lyse a CTX-M-15 Extended Spectrum β-Lactamase Producing Salmonella enterica Serovar Typhi Strain from the Democratic Republic of the Congo
Elene Kakabadze et al.
VIRUSES-BASEL (2018)
Criteria for Selecting Suitable Infectious Diseases for Phage Therapy
David R. Harper
VIRUSES-BASEL (2018)
Development and Validation of a Microtiter Plate-Based Assay for Determination of Bacteriophage Host Range and Virulence
Yicheng Xie et al.
VIRUSES-BASEL (2018)
Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review
Martina Rossitto et al.
FRONTIERS IN MICROBIOLOGY (2018)
Phage Therapy for a MultidrugResistant Acinetobacter baumannii Craniectomy Site Infection
Stephanie LaVergne et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Streamlining standard bacteriophage methods for higher throughput
Kathryn M. Kauffman et al.
METHODSX (2018)
Editorial: Phage Therapy: Past, Presentand Future
Stephen T. Abedon et al.
FRONTIERS IN MICROBIOLOGY (2017)
Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of Bacteremia
Sabrina I. Green et al.
SCIENTIFIC REPORTS (2017)
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Danish J. Malik et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2017)
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection
Robert T. Schooley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Isolation of Polyvalent Bacteriophages by Sequential Multiple-Host Approaches
Pingfeng Yu et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2016)
Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates
V-P. Friman et al.
JOURNAL OF EVOLUTIONARY BIOLOGY (2016)
Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections
James M. Regeimbal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Genetically Engineered Phages: a Review of Advances over the Last Decade
Diana P. Pires et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)
Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences
Nina Chanishvili
CURRENT DRUG DELIVERY (2016)
Bacteriophage Procurement for Therapeutic Purposes
Beata Weber-Dabrowska et al.
FRONTIERS IN MICROBIOLOGY (2016)
Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent
Ia Kusradze et al.
FRONTIERS IN MICROBIOLOGY (2016)
Diversity of phage infection types and associated terminology: the problem with 'Lytic or lysogenic'
Zack Hobbs et al.
FEMS MICROBIOLOGY LETTERS (2016)
Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections
Diana P. Pires et al.
JOURNAL OF VIROLOGY (2015)
Population Dynamics of a Salmonella Lytic Phage and Its Host: Implications of the Host Bacterial Growth Rate in Modelling (vol 9, e102507, 2014)
Silvio B. Santos et al.
PLOS ONE (2015)
Isolation of Phages for Phage Therapy: A Comparison of Spot Tests and Efficiency of Plating Analyses for Determination of Host Range and Efficacy (vol 10, e0118557, 2015)
Mohammadali Khan Mirzaei et al.
PLOS ONE (2015)
Amplification and Purification of T4-Like Escherichia coli Phages for Phage Therapy: from Laboratory to Pilot Scale
Gilles Bourdin et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients
E. Saussereau et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Evaluation of a lytic bacteriophage, Φ st1, for biocontrol of Salmonella enterica serovar Typhimurium in chickens
Chuan Loo Wong et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2014)
Characterization of a virulent bacteriophage LK1 specific for Citrobacter freundii isolated from sewage water
Waqas Nasir Chaudhry et al.
JOURNAL OF BASIC MICROBIOLOGY (2014)
Four Escherichia coli O157:H7 Phages: A New Bacteriophage Genus and Taxonomic Classification of T1-Like Phages
Yan D. Niu et al.
PLOS ONE (2014)
The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages
James J. Bull et al.
FRONTIERS IN MICROBIOLOGY (2014)
Synergy as a rationale for phage therapy using phage cocktails
Matthew Schmerer et al.
PEERJ (2014)
Predicting In Vivo Efficacy of Therapeutic Bacteriophages Used To Treat Pulmonary Infections
Marine Henry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Potential of bacteriophage φAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii
Li-Kuang Chen et al.
BMC MICROBIOLOGY (2013)
Back to the future: evolving bacteriophages to increase their effectiveness against the pathogen Pseudomonas aeruginosa PAO1
Alex Betts et al.
EVOLUTIONARY APPLICATIONS (2013)
The Lactococcal Phages Tuc2009 and TP901-1 Incorporate Two Alternate Forms of Their Tail Fiber into Their Virions for Infection Specialization
Stephen R. Stockdale et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Romulus and Remus, Two Phage Isolates Representing a Distinct Clade within the Twortlikevirus Genus, Display Suitable Properties for Phage Therapy Applications
Katrien Vandersteegen et al.
JOURNAL OF VIROLOGY (2013)
The host-range, genomics and proteomics of Escherichia coli O157:H7 bacteriophage rV5
Andrew M. Kropinski et al.
VIROLOGY JOURNAL (2013)
Effects of Sequential and Simultaneous Applications of Bacteriophages on Populations of Pseudomonas aeruginosa In Vitro and in Wax Moth Larvae
Alex R. Hall et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2012)
Genomic, Proteomic and Physiological Characterization of a T5-like Bacteriophage for Control of Shiga Toxin-Producing Escherichia coli O157:H7
Yan D. Niu et al.
PLOS ONE (2012)
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens
Ben Burrowes et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Rapid and quantitative automated measurement of bacteriophage activity against cystic fibrosis isolates of Pseudomonas aeruginosa
C. J. Cooper et al.
JOURNAL OF APPLIED MICROBIOLOGY (2011)
Microbiological and Molecular Assessment of Bacteriophage ISP for the Control of Staphylococcus aureus
Katrien Vandersteegen et al.
PLOS ONE (2011)
Improved Adsorption of an Enterococcus faecalis Bacteriophage ΦEF24C with a Spontaneous Point Mutation
Jumpei Uchiyama et al.
PLOS ONE (2011)
The Phage Therapy Paradigm: Prt-A -Porter or Sur-mesure?
Jean-Paul Pirnay et al.
PHARMACEUTICAL RESEARCH (2011)
Metagenomic detection of phage-encoded platelet-binding factors in the human oral cavity
Dana Willner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Phage Choice, Isolation, and Preparation for Phage Therapy
Jason J. Gill et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Phage Therapy in Clinical Practice: Treatment of Human Infections
Elizabeth Kutter et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
UNDER THE MICROSCOPE Bacteriophage applications: where are we now?
A. B. Monk et al.
LETTERS IN APPLIED MICROBIOLOGY (2010)
Bacteriophage Receptors, Mechanisms of Phage Adsorption and Penetration into Host Cell
D. V. Rakhuba et al.
POLISH JOURNAL OF MICROBIOLOGY (2010)
Host range and lytic capability of four bacteriophages against bovine and clinical human isolates of Shiga toxin-producing Escherichia coli O157:H7
Y. D. Niu et al.
JOURNAL OF APPLIED MICROBIOLOGY (2009)
Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
Maya Merabishvili et al.
PLOS ONE (2009)
Quantitative Models of In Vitro Bacteriophage-Host Dynamics and Their Application to Phage Therapy
Benjamin J. Cairns et al.
PLOS PATHOGENS (2009)
The evolution of specificity in evolving and coevolving antagonistic interactions between a bacteria and its phage
Virginie Poullain et al.
EVOLUTION (2008)
Isolation and characterization of a new T-even bacteriophage, CEV1, and determination of its potential to reduce Escherichia coli O157:H7 levels in sheep
Raul R. Raya et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
The prospect for bacteriophage therapy in Western medicine
C Merril et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Host-pathogen interactions: The attributes of virulence
A Casadevall et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals
RJH Payne et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
